73.05
price down icon0.77%   -0.57
 
loading
前日終値:
$73.62
開ける:
$73.63
24時間の取引高:
352.69K
Relative Volume:
0.72
時価総額:
$5.27B
収益:
-
当期純損益:
$-224.29M
株価収益率:
-21.05
EPS:
-3.47
ネットキャッシュフロー:
$-153.27M
1週間 パフォーマンス:
-6.30%
1か月 パフォーマンス:
-2.48%
6か月 パフォーマンス:
-26.29%
1年 パフォーマンス:
-2.72%
1日の値動き範囲:
Value
$72.64
$74.52
1週間の範囲:
Value
$71.95
$79.03
52週間の値動き範囲:
Value
$61.80
$113.51

Nuvalent Inc Stock (NUVL) Company Profile

Name
名前
Nuvalent Inc
Name
セクター
Healthcare (1166)
Name
電話
508-446-2272
Name
住所
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
NUVL's Discussions on Twitter

NUVL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NUVL
Nuvalent Inc
73.05 5.27B 0 -224.29M -153.27M -3.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Nuvalent Inc Stock (NUVL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-14 アップグレード UBS Neutral → Buy
2024-12-30 開始されました H.C. Wainwright Buy
2024-10-24 開始されました UBS Neutral
2024-08-29 開始されました Barclays Overweight
2024-04-17 開始されました Jefferies Buy
2024-04-01 アップグレード Leerink Partners Market Perform → Outperform
2024-02-28 再開されました Guggenheim Buy
2024-02-23 開始されました Robert W. Baird Outperform
2023-09-27 開始されました Stifel Buy
2023-08-08 開始されました SVB Securities Market Perform
2023-07-24 開始されました Guggenheim Buy
2023-01-18 開始されました Wedbush Outperform
2022-06-24 開始されました BMO Capital Markets Outperform
すべてを表示

Nuvalent Inc (NUVL) 最新ニュース

pulisher
09:33 AM

Nuvalent chief development officer sells shares worth $292,468 By Investing.com - Investing.com Philippines

09:33 AM
pulisher
Mar 28, 2025

Nuvalent chief development officer sells shares worth $292,468 - Investing.com India

Mar 28, 2025
pulisher
Mar 26, 2025

10 Best Mid Cap Biotech Stocks to Buy - Insider Monkey

Mar 26, 2025
pulisher
Mar 25, 2025

Breakthrough Cancer Drug Data: New Brain-Penetrant Therapy Shows Promise Against Resistant Tumors - StockTitan

Mar 25, 2025
pulisher
Mar 22, 2025

How the (NUVL) price action is used to our Advantage - Stock Traders Daily

Mar 22, 2025
pulisher
Mar 21, 2025

Raymond James Financial Inc. Acquires Shares of 133,964 Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

Nuvalent CEO Porter sells $2.05 million in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Nuvalent CEO Porter sells $2.05 million in stock - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Victory Capital Management Inc. Cuts Stock Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 19, 2025
pulisher
Mar 19, 2025

Charles Schwab Investment Management Inc. Buys 7,742 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

US Bancorp DE Invests $90,000 in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 18, 2025
pulisher
Mar 15, 2025

Bank of New York Mellon Corp Increases Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

UBS Upgrades Nuvalent (NUVL) - Nasdaq

Mar 14, 2025
pulisher
Mar 14, 2025

Nuvalent upgraded to Buy from Neutral at UBS - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

UBS Upgrades Nuvalent to Buy From Neutral, Maintains $100 Price Target -March 14, 2025 at 07:24 am EDT - Marketscreener.com

Mar 14, 2025
pulisher
Mar 08, 2025

Principal Financial Group Inc. Cuts Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

HC Wainwright Has Negative Forecast for Nuvalent Q1 Earnings - Defense World

Mar 06, 2025
pulisher
Mar 04, 2025

Nuvalent’s (NUVL) Buy Rating Reaffirmed at HC Wainwright - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

H.C. Wainwright maintains Buy on Nuvalent stock, $110 target By Investing.com - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

New York State Common Retirement Fund Sells 2,495 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Where are the Opportunities in (NUVL) - Stock Traders Daily

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Has $3.95 Million Stake in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Nuvalent’s Strategic Advances in NSCLC Trials Justify Buy Rating - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Nuvalent to Participate in Upcoming March Investor Conferences - Citizentribune

Feb 28, 2025
pulisher
Feb 28, 2025

Nuvalent, Inc. Reports 2024 Financial Results and Pipeline Progress - TipRanks

Feb 28, 2025
pulisher
Feb 27, 2025

Nuvalent Outlines Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2024 Financial Results - The Malaysian Reserve

Feb 27, 2025
pulisher
Feb 27, 2025

Nuvalent's Q4 Net Loss Widens -February 27, 2025 at 07:14 am EST - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings Flash (NUVL) Nuvalent Posts Q4 Net Loss $1.05 a Share, vs. FactSet Est of $1.08 Loss - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Nuvalent, Inc. SEC 10-K Report - TradingView

Feb 27, 2025
pulisher
Feb 26, 2025

Nuvalent director Shair sells $156,863 in class A common stock By Investing.com - Investing.com Australia

Feb 26, 2025
pulisher
Feb 26, 2025

State of New Jersey Common Pension Fund D Has $1.81 Million Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Feb 26, 2025
pulisher
Feb 26, 2025

Nuvalent director Shair sells $156,863 in class A common stock - Investing.com India

Feb 26, 2025
pulisher
Feb 23, 2025

Nuvalent (NUVL) Projected to Post Earnings on Tuesday - Defense World

Feb 23, 2025
pulisher
Feb 21, 2025

Nuvalent CEO sells stock worth over $2.1 million By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Nuvalent CEO sells stock worth over $2.1 million - Investing.com India

Feb 21, 2025
pulisher
Feb 18, 2025

(NUVL) Proactive Strategies - Stock Traders Daily

Feb 18, 2025
pulisher
Feb 18, 2025

Nuvalent (NUVL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat

Feb 18, 2025
pulisher
Feb 14, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives $112.36 Consensus Target Price from Analysts - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

Q1 Earnings Estimate for Nuvalent Issued By Leerink Partnrs - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

abrdn plc Buys 9,241 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives $112.36 Consensus PT from Brokerages - Defense World

Feb 13, 2025
pulisher
Feb 11, 2025

10 Mid-Cap Stocks Insiders Are Selling Recently - Insider Monkey

Feb 11, 2025
pulisher
Feb 11, 2025

Why Insiders Are Selling Nuvalent, Inc. (NUVL) Recently - Insider Monkey

Feb 11, 2025
pulisher
Feb 08, 2025

KBC Group NV Boosts Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Feb 08, 2025
pulisher
Feb 08, 2025

What is Leerink Partnrs’ Forecast for Nuvalent Q2 Earnings? - Defense World

Feb 08, 2025
pulisher
Feb 07, 2025

Long Term Trading Analysis for (NUVL) - Stock Traders Daily

Feb 07, 2025
pulisher
Feb 05, 2025

Nuvalent (NASDAQ:NUVL) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Feb 05, 2025
pulisher
Feb 04, 2025

The Potential Rise in the Price of Nuvalent Inc (NUVL) following insiders activity - Knox Daily

Feb 04, 2025

Nuvalent Inc (NUVL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Nuvalent Inc (NUVL) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Noci Darlene
Chief Development Officer
Mar 27 '25
Sale
73.12
4,000
292,468
48,034
Porter James Richard
President and CEO
Mar 17 '25
Option Exercise
27.85
27,000
751,950
276,062
Porter James Richard
President and CEO
Mar 17 '25
Sale
75.87
27,000
2,048,562
249,062
Noci Darlene
Chief Development Officer
Mar 06 '25
Option Exercise
2.63
30,000
78,967
78,034
Noci Darlene
Chief Development Officer
Mar 07 '25
Option Exercise
1.08
4,000
4,320
52,034
Noci Darlene
Chief Development Officer
Mar 06 '25
Sale
71.86
30,000
2,155,857
48,034
Noci Darlene
Chief Development Officer
Mar 07 '25
Sale
71.93
4,000
287,721
48,034
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):